You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華北製藥(600812.SH):發行股份購買資產並募集配套資金事項獲證監會核准
格隆匯 11-06 18:45

格隆匯 11 月 6日丨華北製藥(600812.SH)公佈,公司於2020年11月6日收到中國證券監督管理委員會(以下簡稱“中國證監會”)出具的《關於核准華北製藥股份有限公司向華北製藥集團有限責任公司發行股份購買資產並募集配套資金的批覆》(證監許可[2020]【2875】號),批覆內容如下:

“一、核准你公司向華北製藥集團有限責任公司發行84,925,641股股份購買相關資產。

二、核准你公司發行股份募集配套資金不超過5.5億元。

三、你公司本次發行股份購買資產並募集配套資金應當嚴格按照報送我會的方案及有關申請文件進行。

四、你公司應當按照有關規定及時履行信息披露義務。

五、你公司應當按照有關規定辦理本次發行股份的相關手續。

六、本批覆自下發之日起12個月內有效。

七、你公司在實施過程中,如發生法律、法規要求披露的重大事項或遇重大問題,應當及時報告我會。”公司將根據相關法律法規和上述核准文件要求及公司股東大會的授權,儘快辦理本次發行股份及支付現金購買資產並募集配套資金暨關聯交易相關事宜,並根據實施進展情況及時履行信息披露義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account